Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 16
Submit an article Journal homepage
348
Views
39
CrossRef citations to date
0
Altmetric
Reviews

Safety of hymenoptera venom immunotherapy: a systematic review

Cristoforo IncorvaiaAllergy/Pulmonary Rehabilitation, Istituti Clinici di Perfezionamento, Via Bignami 1, 20126 Milan, Italy+39 02 5799 3289; +39 02 5799 3262; [email protected]
,
Franco FratiScientific Department, Stallergenes, viale Certosa2, 20155 Milan, Italy
,
Ilaria Dell'AlbaniScientific Department, Stallergenes, viale Certosa2, 20155 Milan, Italy
,
Anna Robino Niguarda Ca' Granda Hospital, Unit of Allergology and Immunology, piazza Ospedale Maggiore 3, 20162 Milan, Italy
,
Eleonora CattaneoScientific Department, Stallergenes, viale Certosa2, 20155 Milan, Italy
,
Marina Mauro Sant'Anna Hospital,Allergy Service, via Napoleona 60, 22100 Como, Italy
,
Marie DavidScientific Department, Stallergenes, rue Alexis de Tocqueville 92183 Antony, France
,
Rosanna Qualizza Allergy Service, Istituti Clinici di Perfezionamento, via Farini 9, 20154 Milan, Italy
&
Elide Pastorello Niguarda Ca' Granda Hospital, Unit of Allergology and Immunology, piazza Ospedale Maggiore 3, 20162 Milan, Italy
 show all
Pages 2527-2532 | Published online: 02 Sep 2011

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Cristoforo Incorvaia, Marina Mauro, Bruna L. Gritti, Eleni Makri & Erminia Ridolo. (2018) Venom immunotherapy in patients with allergic reactions to insect stings. Expert Review of Clinical Immunology 14:1, pages 53-59.
Read now
Jessica Stanhope, Scott Carver & Philip Weinstein. (2017) Health outcomes of beekeeping: a systematic review. Journal of Apicultural Research 56:2, pages 100-111.
Read now
Mitja Kosnik & Peter Korosec. (2015) Venom immunotherapy: clinical efficacy, safety and contraindications. Expert Review of Clinical Immunology 11:8, pages 877-884.
Read now
Franco Frati, Erminia Ridolo, Nicola Fuiano, Salvatore Barberi, Ilaria Dell’Albani, Massimo Landi, Luisa Ricciardi, Guglielmo Scala & Cristoforo Incorvaia. (2014) Safety of sublingual immunotherapy in children. Expert Opinion on Drug Safety 13:7, pages 947-953.
Read now

Articles from other publishers (35)

Antonia Glaeser, Christoph Müller & Sebastian Bode. (2022) Anaphylactic reactions in the build-up phase of rush immunotherapy for bee venom allergy in pediatric patients: a single-center experience. Clinical and Molecular Allergy 20:1.
Crossref
Valerio Pravettoni, Marina Mauro, Federica Rivolta, Dario Consonni, Camilla Cappelletti, Alessandra Chiei Gallo, Andrea Sangalli & Maria Beatrice Bilò. (2022) Venom immunotherapy: safety and tolerability of the build‐up phase with depot versus aqueous preparations. Clinical & Experimental Allergy 52:10, pages 1230-1233.
Crossref
E. Clark, A. Schiffmann, A. Jentzer, P. Demoly, P. Guilpain & D. Caimmi. (2022) Prise en charge diagnostique et thérapeutique des syndromes d’activation mastocytaire. Revue Française d'Allergologie 62:5, pages 492-496.
Crossref
Cristoforo Incorvaia, Erminia Ridolo, Marina Mauro, Francesco Pucciarini, Enrico Heffler & Giorgio Walter Canonica. (2022) Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?. Frontiers in Allergy 3.
Crossref
Roberta Zanotti, Massimiliano Bonifacio, Cecilia Isolan, Ilaria Tanasi, Lara Crosera, Francesco Olivieri, Giovanni Orsolini, Donatella Schena & Patrizia Bonadonna. (2021) A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years’ Experience of the GISM Network. Cancers 13:24, pages 6380.
Crossref
Marta Burzyńska & Dorota Piasecka-Kwiatkowska. (2021) A Review of Honeybee Venom Allergens and Allergenicity. International Journal of Molecular Sciences 22:16, pages 8371.
Crossref
Roberta Scarpone, Elsbeth Oestmann, Magdalena Kraft & Margitta Worm. (2020) Good tolerability when switching from an aqueous ultra‐rush Hymenoptera venom immunotherapy to a depot preparation. Allergy 75:7, pages 1800-1802.
Crossref
Patrizia Bonadonna & Roberta Zanotti. 2020. Mastocytosis. Mastocytosis 157 174 .
Shuaib Nasser, Andrew F. Whyte, Stephen R. Durham & Mamidipudi Thirumala Krishna. (2019) Switch‐over from Pharmalgen to Alutard Bee and Wasp venom in the UK. Clinical & Experimental Allergy 49:12, pages 1645-1646.
Crossref
Patrizia Bonadonna, Luigi Scaffidi & Elisa Boni. (2019) Tryptase values in anaphylaxis and insect allergy. Current Opinion in Allergy & Clinical Immunology 19:5, pages 462-467.
Crossref
Manuela B. Pucca, Felipe A. Cerni, Isadora S. Oliveira, Timothy P. Jenkins, Lídia Argemí, Christoffer V. Sørensen, Shirin Ahmadi, José E. Barbosa & Andreas H. Laustsen. (2019) Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy. Frontiers in Immunology 10.
Crossref
Robert Heddle, Anthony Smith, Richard Woodman, Pravin Hissaria & Nikolai Petrovsky. (2019) Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy. Journal of Allergy and Clinical Immunology 144:2, pages 504-513.e16.
Crossref
Stefano Pucci, Fedra Ciccarelli, Tiziana De Pasquale, Ilenia Illuminati & Simona D'Alò. (2018) Depot extracts for rush venom immunotherapy. Annals of Allergy, Asthma & Immunology 121:3, pages 376-377.
Crossref
Patrizia Bonadonna & Luigi Scaffidi. (2018) Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder. Immunology and Allergy Clinics of North America 38:3, pages 455-468.
Crossref
G. J. Sturm, E.-M. Varga, G. Roberts, H. Mosbech, M. B. Bilò, C. A. Akdis, D. Antolín-Amérigo, E. Cichocka-Jarosz, R. Gawlik, T. Jakob, M. Kosnik, J. Lange, E. Mingomataj, D. I. Mitsias, M. Ollert, J. N. G. Oude Elberink, O. Pfaar, C. Pitsios, V. Pravettoni, F. Ruëff, B. A. Sin, I. Agache, E. Angier, S. Arasi, M. A. Calderón, M. Fernandez-Rivas, S. Halken, M. Jutel, S. Lau, G. B. Pajno, R. van Ree, D. Ryan, O. Spranger, R. G. van Wijk, S. Dhami, H. Zaman, A. Sheikh & A. Muraro. (2018) EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy 73:4, pages 744-764.
Crossref
J. A. Dantzer & R. A. Wood. (2018) The use of omalizumab in allergen immunotherapy. Clinical & Experimental Allergy 48:3, pages 232-240.
Crossref
Irene Martignago, Cristoforo Incorvaia & Erminia Ridolo. (2017) Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence. Clinical and Molecular Allergy 15:1.
Crossref
Amilcar Perez-Riverol, José Roberto Aparecido dos Santos-Pinto, Alexis Musacchio Lasa, Mario Sergio Palma & Márcia Regina Brochetto-Braga. (2017) Wasp venomic: Unravelling the toxins arsenal of Polybia paulista venom and its potential pharmaceutical applications. Journal of Proteomics 161, pages 88-103.
Crossref
Claudia Fiedler, Ulrich Miehe, Regina Treudler, Wieland Kiess & Freerk Prenzel. (2017) Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines. International Archives of Allergy and Immunology 172:3, pages 167-172.
Crossref
Robbie Pesek & Richard F. Lockey. 2017. Stinging Insect Allergy. Stinging Insect Allergy 125 140 .
Elisa Boni, Cristoforo Incorvaia & Marina Mauro. (2016) Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab. Clinical and Molecular Allergy 14:1.
Crossref
L. Ricciardi. (2016) Omalizumab: A useful tool for inducing tolerance to bee venom immunotherapy. International Journal of Immunopathology and Pharmacology 29:4, pages 726-728.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 882 886 .
Patrizia Bonadonna, Massimiliano Bonifacio, Carla Lombardo & Roberta Zanotti. (2015) Hymenoptera Allergy and Mast Cell Activation Syndromes. Current Allergy and Asthma Reports 16:1.
Crossref
Eishin Morita. 2016. Immunology of the Skin. Immunology of the Skin 419 427 .
Amilcar Perez-Riverol, Débora Justo-Jacomini, Ricardo Zollner & Márcia Brochetto-Braga. (2015) Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens. Toxins 7:7, pages 2551-2570.
Crossref
Jeong Hwan Park, Bo Kyung Yim, Jun-Hwan Lee, Sanghun Lee & Tae-Hun Kim. (2015) Risk Associated with Bee Venom Therapy: A Systematic Review and Meta-Analysis. PLOS ONE 10:5, pages e0126971.
Crossref
Berta Ruiz, Pilar Serrano, Miriam Verdú & Carmen Moreno. (2015) Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy. Annals of Allergy, Asthma & Immunology 114:4, pages 350-352.
Crossref
Scott H. Sicherer. 2015. Allergy and Clinical Immunology. Allergy and Clinical Immunology 278 287 .
Libia Susana Díez Zuluaga, Ricardo Cardona Villa, María Nelly Restrepo Colorado & Jorge Mario Sánchez Caraballo. (2014) Inmunoterapia con alérgenos, ¿cuándo y por qué?. Iatreia 28:1, pages 55-65.
Crossref
Marcus S. Shaker, Derek Hsu & David A. Gruenberg. (2013) An update on venom allergy. Current Opinion in Pediatrics 25:5, pages 629-634.
Crossref
Patrizia Bonadonna, David Gonzalez-de-Olano, Roberta Zanotti, Annamaria Riccio, Laura De Ferrari, Carla Lombardo, Anthi Rogkakou, Luis Escribano, Ivan Alvarez-Twose, Almudena Matito, Arantza Vega & Giovanni Passalacqua. (2013) Venom Immunotherapy in Patients with Clonal Mast Cell Disorders: Efficacy, Safety, and Practical Considerations. The Journal of Allergy and Clinical Immunology: In Practice 1:5, pages 474-478.
Crossref
Tyson C. Brown. (2013) Reactions to honeybee stings. Current Opinion in Allergy & Clinical Immunology 13:4, pages 365-371.
Crossref
M Beatrice BilòLeonardo Antonicelli & Floriano Bonifazi. (2012) Honeybee venom immunotherapy: certainties and pitfalls. Immunotherapy 4:11, pages 1153-1166.
Crossref
. (2012) Current World Literature. Current Opinion in Allergy & Clinical Immunology 12:4, pages 440-445.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.